Old Web
English
Sign In
Acemap
>
authorDetail
>
Kuo Shun Hsu
Kuo Shun Hsu
National Health Research Institutes
Cell culture
Molecular biology
Cancer cell
In vitro
Tubulin
3
Papers
173
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Novel Oral Indoline-Sulfonamide Agent, N-[1-(4-Methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-Isonicotinamide (J30), Exhibits Potent Activity against Human Cancer Cells in Vitro and in Vivo through the Disruption of Microtubule
2007
Journal of Pharmacology and Experimental Therapeutics
Jing Ping Liou
Kuo Shun Hsu
Ching-Chuan Kuo
Chi Yen Chang
Jang-Yang Chang
Show All
Source
Cite
Save
Citations (55)
D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia–mutated nuclear protein kinase activation
2007
Molecular Cancer Therapeutics
Shin-Hun Juang
Chia Chi Lung
Pi-Chen Hsu
Kuo Shun Hsu
Yu Chen Li
Pao-Chiung Hong
Her-Shyong Shiah
Ching-Chuan Kuo
Ching-Wei Huang
Yu-Chin Wang
Leeyuan Huang
Tom S. Chen
Shyh-Fong Chen
Kuo Chu Fu
Cheng Li Hsu
Meng-Ju Lin
Ching-Jer Chang
Curtis L. Ashendel
Thomas C. K. Chan
Kai Ming Chou
Jang Chang Chang
Show All
Source
Cite
Save
Citations (56)
7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
2006
Journal of Medicinal Chemistry
Jang-Yang Chang
Hsing-Pang Hsieh
Chi Yen Chang
Kuo Shun Hsu
Yi Fang Chiang
Chi-Ming Chen
Ching-Chuan Kuo
Jing Ping Liou
Show All
Source
Cite
Save
Citations (62)
1